Study: Nearly half of heart attack and stroke survivors don’t know their LDL cholesterol levels

Nek­tar Ther­a­peu­tics said its for­mer part­ner Eli Lil­ly had pre­sent­ed “er­ro­neous da­ta” for its atopic der­mati­tis drug be­fore break­ing off a $400 mil­lion al­liance. Where­as

An investigational anti-interleukin (IL)-13 monoclonal antibody reduced eczema symptoms and was well-tolerated in adults with moderate to severe atopic dermatitis, a randomized phase II study